Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Cellebrite DI (CLBT) Debt to Equity: 2020-2025

Historic Debt to Equity for Cellebrite DI (CLBT) over the last 5 years, with Sep 2025 value amounting to $0.01.

  • Cellebrite DI's Debt to Equity rose 213.28% to $0.01 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.01, marking a year-over-year increase of 213.28%. This contributed to the annual value of $0.02 for FY2024, which is 87.16% down from last year.
  • Latest data reveals that Cellebrite DI reported Debt to Equity of $0.01 as of Q3 2025, which was up 3.44% from $0.01 recorded in Q2 2025.
  • Over the past 5 years, Cellebrite DI's Debt to Equity peaked at $0.22 during Q1 2022, and registered a low of -$3.46 during Q2 2023.
  • For the 3-year period, Cellebrite DI's Debt to Equity averaged around -$0.29, with its median value being $0.00 (2024).
  • Per our database at Business Quant, Cellebrite DI's Debt to Equity crashed by 4,485,124.07% in 2022 and then surged by 184,832.02% in 2025.
  • Cellebrite DI's Debt to Equity (Quarterly) stood at -$0.13 in 2021, then surged by 156.16% to $0.07 in 2022, then spiked by 120.75% to $0.16 in 2023, then plummeted by 87.16% to $0.02 in 2024, then skyrocketed by 213.28% to $0.01 in 2025.
  • Its Debt to Equity was $0.01 in Q3 2025, compared to $0.01 in Q2 2025 and $0.01 in Q1 2025.